Human visceral leishmaniasis: decrease in serum cholesterol as a function of splenic parasite load

By Ghosh J   Lal C S   Pandey K   Das V N R   Das P   Roychoudhury K   Roy S  

Annals of Tropical Medicine and Parasitology, Vol. 105, Iss. 3, 2011-04 ,pp. : 267-271

Maney Publishing

Access to resources Recommend Favorite

Visceral Leishmaniasis in an AIDS Patient on Successful Antiretroviral Therapy: Failure of Parasite Eradication Despite Increase in CD4⁺ T-Cell Count but Low CD8⁺ T-Cell Count

By Petter Anton   Shetty-Lee Angela   Kofler Gabriele   Huemer Hartwig P.   Larcher Clara  

Scandinavian Journal of Infectious Diseases, Vol. 33, Iss. 3, 2001-03 ,pp. : 236-238

Informa Healthcare

Access to resources Recommend Favorite

Fatal visceral leishmaniasis, with massive bone-marrow infection, in an immunosuppressed but HIV-negative Spanish patient, after the initiation of treatment with meglumine antimoniate

By Garcia-Cordoba F.   Ortuño F.J.   Segovia M.   Gonzalez Diaz G.  

Annals of Tropical Medicine and Parasitology, Vol. 99, Iss. 2, 2005-03 ,pp. : 125-130

Maney Publishing

Access to resources Recommend Favorite

Increased expression of HIV co-receptor CXCR4 on CD4+ T-cells in patients with active visceral leishmaniasis

By Hailu Asrat   Pater Jennie   Kager Piet   van der Poll Tom  

Scandinavian Journal of Infectious Diseases, Vol. 36, Iss. 1, 2004-01 ,pp. : 56-58

Informa Healthcare

Access to resources Recommend Favorite

The impact of highly active antiretroviral therapy (HAART) on visceral leishmaniasis in Spanish patients who are co-infected with HIV

By López-Vélez R.  

Annals of Tropical Medicine and Parasitology, Vol. 97, Iss. 1, 2003-10 ,pp. : 143-147

Maney Publishing

Access to resources Recommend Favorite